论文部分内容阅读
上海市中心血站自1971年开始,为了解决血源紧张、输血并发症等问题,与第三人民医院、长征医院等单位密切合作,开展了自身输血的研究工作,取得了较好的成效。但在血浆和自身输血的实践中,迫切需要解决选择合适的血浆代用品作血液稀释剂。为此,他们与有关临床单位进一步协作,根据急性大量失血和血液稀释后机体生理变化的特点,研制成功了一种代血浆制剂——电解质平衡代血浆(羟乙基淀粉乙酸盐平衡注射液)。
Starting from 1971, Shanghai Blood Center has worked closely with the Third People’s Hospital and the Changzheng Hospital to solve the problems of blood supply and blood transfusion complications and carried out research on its own blood transfusion and achieved good results. However, in the practice of blood plasma and blood transfusion, there is an urgent need to solve the problem of choosing a suitable blood plasma substitute for blood thinners. To this end, they further collaboration with the relevant clinical units, according to the characteristics of acute and massive blood loss and physiological changes after hemodilution, the successful development of a generation of plasma agents - electrolyte balance on behalf of plasma (hydroxyethyl starch acetate balance injection ).